UK parliamentary committees demand probe into cost of US-UK pharma trade deal

Six UK parliamentary committees have written to the relevant watchdog asking for an investigation into the cost of the United Kingdom's pharmaceutical trade agreement with the United States.

The committees say the deal may not be delivering sufficient value for the National Health Service and request greater transparency on pricing structures and any subsidies involved.

Their request could prompt a formal inquiry if the watchdog finds the concerns justified, putting pressure on the government to review the agreement.